Skip to main content
SpringerLink
Log in
Book cover

Basic Aspects of Receptor Biochemistry pp 189–204Cite as

Interactions of Ergot Compounds with Dopamine Receptors and Endocrine Functions

  • Conference paper

  • 43 Accesses

Part of the book series: Journal of Neural Transmission ((NEURAL SUPPL,volume 18))

Summary

Ergot compounds may affect endocrine systems through stimulatory and inhibitory dopamine receptors at the hypothalamic and the pituitary level. In most cases, with the exception of the prolactin and the melanotropin cell receptors, the characterization of the dopamine receptor involved is not yet satisfactory. Comparing in vivo or in vitro dopaminomimetic activities of ergot compounds produces a multiplicity of profiles of actions without a clear pattern.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adams, E. F., Ashby, M.J., Brown, S. M., White, M. C., Mashiter, K.: Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism. Clin. Endocrinol. 15, 479–484 (1981).

    Article  CAS  Google Scholar 

  • Agnati, L., Fuxe, K., Löfström, A., Hökfelt, T: Dopaminergic drugs and ovulation: Studies on PMS-induced ovulation and changes in median eminence DA and NE turnover in immature female rats. In: Advances in Biochemical Psychopharmacology (Costa, E., Gessa, G. L., eds.), p. 159. New York: Raven Press. 1977.

    Google Scholar 

  • Bansal, S., Woolf, P. D., Fischer, J.A., Caro, J. F.: Dopamine does not affect parathyroid function in man. J. Clin. Endocrinol. Metab. 54, 651–652 (1982).

    Article  CAS  PubMed  Google Scholar 

  • Bethea, C. L., Ramsdell, J. S.,Jaffe, R. B., Wildson, C. B., Weiner, R.I.: Characterization of the dopaminergic regulation of human prolactin secreting cells cultured on extracellular matrix. J. Clin. Endocrinol. Metab. 54, 893–902 (1982).

    CAS  Google Scholar 

  • Bevilacqua, M., Vago, T, Malacco, E., Norblato, G.: Characterization of dopaminergic receptors in calf adrenal glomerulosa cells. Abstract, Symp. on Dopamine Receptor Agonists, Stockholm, April 20–23, 1982.

    Google Scholar 

  • Bisset, G. W.: The milk ejection reflex. In: Neurohypophysial Hormones and Similar Peptides (Berde, B., ed.) (Handbook of Exp. Pharmacology, Vol. XXIII), p. 475. Berlin-Heidelberg-New York: Springer. 1968.

    Chapter  Google Scholar 

  • Blum, J. W., Kunz, P., Fischer, J. A., Binswanger, U., Lichtensteiger, W, da Prada, M.: Parathyroid hormone response to dopamine in cattle. Am. J. Physiol. 239, 255–264 (1980).

    Google Scholar 

  • Bression, D., Brandi, A. M., Nousbaum, A., LeDafniet, M., Racadot, J., Peilion, F.: Evidence of dopamine receptors in human growth hormone (GH)-secreting adenomas with concomitant study of dopamine inhibition of GH secretion in a perifused system. J. Clin. Endocrinol. Metab. 55, 589–593 (1982).

    Article  CAS  PubMed  Google Scholar 

  • Bridges, T.E., Hillhouse, E. W., Jones, M. T: The effect of dopamine on neurohypophysial hormone release in vivo and from the rat neural lobe and hypothalamus in vitro. J. Physiol. 260, 647–666 (1976).

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Brown, E. M., Caroll, R.J., Aurbach, G. D.: Dopaminergic stimulation of cyclic AMP accumulation and parathyroid hormone release from dispersed bovine parathyroid cells. Proc. Natl. Acad. Sci. USA 74, 4210–4213 (1977).

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Calabro, M.A., MacLeod, R.M.: Binding of dopamine to bovine anterior pituitary gland membranes. Neuroendocrinology 25, 32–46 (1976).

    Article  Google Scholar 

  • Camanni, F., Massara, F., Belforte, L., Molinatti, G. M.: Changes in plasma growth hormone levels in normal and acromegalic subjects following administration of 2-bromo-a-ergokryptine. J. Clin. Endocrinol. Metab. 40, 363–366 (1975).

    Article  CAS  PubMed  Google Scholar 

  • Carey, R. M., Thorner, M. O.: Dopaminergic inhibition of metoclopramide induced aldosterone secretion in man: dissociation of responses to dopamine and bromocriptine. J. Clin. Invest. 66, 10–15 (1980).

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Carey, R. M., Thorner, M. O., Ortt, E.: Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. J. Clin. Invest. 66, 10–18 (1980).

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Carey, R. M., Van Loon, G. R.: Bromocriptine does not inhibit the aldosterone response to sodium depletion. J. Clin. Endocrinol. Metab. 55, 162–165 (1982).

    Article  CAS  PubMed  Google Scholar 

  • Caron, G. M., Beaulieu, M., Raymond, V., Gagne, B., Drouin, J., Lefkowitz, J., Labrie, F.: Dopaminergic receptors in the anterior pituitary gland. J. Biol. Chem. 253, 2244–2253 (1978).

    CAS  PubMed  Google Scholar 

  • Clarke, G., Lincoln, D. W, Merrick, L.P.: Dopaminergic control of oxytocin release in lactating rats. J. Endocr. 83, 409–420 (1979).

    Article  CAS  PubMed  Google Scholar 

  • Connell, J. M. C.: Bromocriptine for inappropriate thyrotropin secretion. Ann. Intern. Med. 96, 251–252 (1982).

    Article  CAS  PubMed  Google Scholar 

  • Cote, T. E., Grewe, C. W, Kebabian, J. W: Stimulation of a D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland decreases the responsiveness of the ß-adrenoceptor: Biochemical mechanism. Endocrinology 108, 420–426 (1981).

    Article  CAS  PubMed  Google Scholar 

  • Cronin, M.J.: The role and direct measurement of the dopamine receptor(s) in the anterior pituitary. In: Neuroendocrine Perspectives, Vol.1 (Müller, E.E., MacLeod, R.M., eds.), p. 169. Amsterdam: Elsevier Biomedical Press. 1982.

    Google Scholar 

  • Cronin, M.J.: Some calcium and lysosome antagonists inhibit 3H-spiperone binding to the porcine anterior pituitary. Life Sci. 30, 1385–1389 (1982).

    Article  CAS  PubMed  Google Scholar 

  • Cronin, M.J., Cheung, C. Y, Wilson, C. B., Jaffe, R. B., Weiner, R. I.: [3H]-spiperone binding to human anterior pituitaries and pituitary adenomas secreting prolactin, growth hormone, and adrenocorticotropic hormone. J. Clin. Endocrinol. Metab. 50, 387–391 (1980).

    Article  CAS  PubMed  Google Scholar 

  • Delitala, G., Yeo, T, Grossman, A., Hathway, N. R., Besser, G. M.: A comparison of the effects of four ergot derivatives on prolactin secretion by dispersed rat pituitary cells. J. Endocr. 87, 95–103 (1980).

    Article  CAS  PubMed  Google Scholar 

  • del Pozo, E., Lancranjan, I.: Clinical use of drugs modifying the release of anterior pituitary hormones. In: Frontiers in Neuroendocrinology (Ganong, W F., Martini, L., eds.), Vol. 5, p. 207. New York: Raven Press. 1978.

    Google Scholar 

  • del Pozo, E., Darragh, A., Lancranjan, 1., Ebeling, D., Burmeister, P., Bühler, F., Marbach, P., Braun, P.: Effect of bromocriptine on the endocrine system and fetal development. Clin. Endocrinol. 6 (Suppl.), 47–55 (1977).

    Google Scholar 

  • Denef, C., Baes, M.: ß-Adrenergic stimulation of prolactin release from superfused pituitary aggregates. Endocrinology 111, 356–358 (1982).

    Article  CAS  PubMed  Google Scholar 

  • El-Denshary, E. E., Ismail, N. A., Gagesman, E., Sehling, J., Täl edal, L-B.: Bromocriptine and insulin secretion. Bioscience Reports 2, 115–116 (1982).

    Article  CAS  PubMed  Google Scholar 

  • Evans, W. S., Rogol, A. D., MacLeod, R.M., Thorner, M. O.: Dopaminergic mechanism and luteinizing hormone secretion. I. Acute administration of the dopamine agonist bromocriptine does not inhibit luteinizing hormone release in hyperprolactinemic women. J. Clin. Endocrinol. 50, 103–107 (1980).

    CAS  PubMed  Google Scholar 

  • Evans, W. S., Cronin, M.J., Thorner, M. O.: Hypogonadism in hyperprolactinemia: Proposed mechanism. In: Frontiers in Neuroendocrinology (Ganong, W. F., Martini, L., eds.), Vol. 7, p. 77. New York: Raven Press. 1982.

    Google Scholar 

  • Flückiger, E.: Lactation inhibition by ergot drugs. In: Physiology of Mammary Glands (Yokoyama, A., Mizouno, H., Nagasawa, H., eds.), p.71. Tokyo: Japan Scientific Societies Press/Baltimore: University Park Press. 1978.

    Google Scholar 

  • Flückiger, E.: Ergots and endocrine functions. In: Ergot Compounds and Brain Function. Neuroendocrine and Neuropsychiatric Aspects (Goldstein, M., Calne, D. B., Liebermann, A., Thorner, M. O., eds.), p. 155. New York: Raven Press. 1980.

    Google Scholar 

  • Flückiger, E.: Inhibitors of prolactin secretion. In: Advances in Pharmacology and Therapeutics II, Vol. 1: CNS Pharmacology, Neuropeptides (Yoshida, H., Hagihara, Y., Ebashi, S., eds.), pp. 129. Oxford: Pergamon Press. 1982.

    Google Scholar 

  • Flückiger, E., del Pozo, E.: Influence on the endocrine system. In: Ergot Alkaloids and Related Compounds (Berde, B., Schild, H. U., eds.) (Handbook of Experimental Pharmacology, Vol.49), p. 615. Berlin-HeidelbergNew York: Springer. 1978.

    Chapter  Google Scholar 

  • Flückiger, E., Vigouret, J.-M., Wagner, H.-R.: Ergot compounds and prolactin secretion. In: Progress in Prolactin Physiology and Pathology (Robyn, C., Harter, M., eds.), p. 383. Amsterdam: Elsevier/North-Holland Biomedical Press. 1978.

    Google Scholar 

  • Flückiger, E., Vigouret, J.-M.: Drugs, dopamine and pituitary secretion. In: Medicinal Chemistry VI, Proc. 6th Internat. Symp. Med. Chem., Brighton, 1978 (Simkins, M. A., ed.), p. 469. Oxford: Cotswold Press. 1979.

    Google Scholar 

  • Flückiger, E., Briner, U., Bürki, H.R., Marbach, P., Wagner, H-R., Doepfner, W.: Two novel prolactin release-inhibiting 8a-amino-ergolines. Experientia 35, 1677–1678 (1979).

    Article  PubMed  Google Scholar 

  • Flückiger, E., del Pozo, E.: Ergot derivatives and pituitary hormones. In: Neuroactive Drugs in Endocrinology (Müller, E.E., ed.), p. 169. Amsterdam: Elsevier/North-Holland Biomedical Press. 1980.

    Google Scholar 

  • Flückiger, E., Briner, U., Kovacs, E., Markstein, R., Stürmer, E., Vigouret, J.-M., Wagner, H.-R.: Prolactin secretion stimulation by an ergopeptine. Experientia 37, 669 (1981).

    Google Scholar 

  • Flückiger, E., Briner, U., Enz, A., Markstein, R., Vigouret, J.-M.: Dopaminergic ergot compounds: An overview. In: Lisuride and Other Dopamine Agonists: Basic Mechanisms and Endocrine and Neurological Effects (Calne, D. B., Horowski, R., McDonald, R., Wuttke, W., eds.), p. 1–9. New York: Raven Press. 1982.

    Google Scholar 

  • Flückiger, E., del Pozo, E., von Werder, K.: Prolactin, Physiology, Pharmacology and Clinical Findings. (Monographs on Endocrinology, Vol. 23.) BerlinHeidelberg-New York: Springer. 1982 b.

    Google Scholar 

  • Flückiger, E., Markstein, R.: Receptor pharmacology of ergot compounds. In: Human Prolactin (Tolis, G., ed). New York: Raven Press. 1982 (in press).

    Google Scholar 

  • Foord, S. M., Peters, Scanlon, M. F., Bees Smith, B., Hall, R.: Dopaminergic control of TSH secretion in isolated rat pituitary cells. FEBS Letters 121, 257–259 (1980).

    CAS  Google Scholar 

  • Grossman, A., Yeo, T, Delitala, G., Hathway, N. R., Besser, G. M.: Two new dopamine agonists that are long acting in vivo but short acting in vitro. Clin. Endocrinol. 13, 595–599 (1980).

    Article  CAS  Google Scholar 

  • Hauth, H.: Chemical aspects of ergot derivatives with central dopaminergic activity. In: Dopaminergic Ergot Derivatives and Motor Function (Fuze, K., Caine, D.B., eds.), p. 23. Oxford: Pergamon Press. 1979.

    Chapter  Google Scholar 

  • Kebabian, J. W., Calne, D.B.: Multiple receptors for dopamine. Nature 277, 93–96 (1979).

    Article  CAS  PubMed  Google Scholar 

  • Kerdelhue, B., Weisman, A. S., Weiner, R. I.: A dopaminergic binding site in the high speed supernatant of steer anterior pituitary homogenates. Endocrinology 109, 307–309 (1981).

    Article  CAS  PubMed  Google Scholar 

  • Köbberling, J., Darragh, A., del Pozo, E.: Chronic dopamine receptor stimulation using bromocriptine: Failure to modify thyroid function. Clin. Endocrinol. 11, 367–370 (1979).

    Article  Google Scholar 

  • Krulich, L.: Neurotransmitter control of thyrotropin secretion. Neuroendocrinology 35, 139–147 (1982).

    Article  CAS  PubMed  Google Scholar 

  • Labrie, F., Borgeat, P., Drouin,J., Lagace, L., Giguere, V., Raymond, V., Godbout, M., Massicotte,J., Ferland, Barden, N., Beaulieu, M., Cote,J., Lepine,J., Meunier, H., Veileux, R.: The role of cyclic nucleotides in the control of anterior pituitary gland activity. In: Cyclic Nucleotides II (Kebabian, J. W., Nathanson,J.A., eds.), p. 525. Berlin-Heidelberg-New York: Springer. 1982.

    Chapter  Google Scholar 

  • Lachelin, G. C. L., Leblanc, H., Yen, S. S. C.: The inhibitory effect of dopamine agonists on LH release in women. J. Clin. Endocrinol. Metab. 44, 728–732 (1977).

    Article  CAS  PubMed  Google Scholar 

  • Lal, S., de la Vega, C. E., Sourkes, T. L., Friesen, H. G.: Effect of apomorphine on human growth hormone secretion. Lancet II, 661 (1972).

    Google Scholar 

  • Lauer, C. G., Braley, L.A., Menachery, A.I., Williams, G. H.: Metoclopramide inhibits aldosterone biosynthesis in vitro. Endocrinology 111, 238–243 (1982).

    Article  CAS  PubMed  Google Scholar 

  • Lawton, N. F., Evans, A.J., Weller, R. O.: Dopaminergic inhibition of growth hormone and prolactin release during continuous in vitro perifusion of normal and adenomatous human pituitary. J. Neurol. Sci. 49, 229–239 (1981).

    Article  CAS  PubMed  Google Scholar 

  • Leblanc, H., Lachelin, G. C. L., Abu-Fadil, S., Yen, S. S. C.: Effects of dopamine infusion on pituitary hormone secretion in humans. J. Clin. Endocrinol. Metab. 43, 668–674 (1976).

    Article  CAS  PubMed  Google Scholar 

  • Lincoln, D. W, Paisley, A. C.: Neuroendocrine control of milk ejection. J. Reprod. Fert. 65, 571–586 (1982).

    Article  CAS  Google Scholar 

  • Liuzzi, A., Chiodini, P. G., Botalla, L., Cremascoli, G., Silvestrini, F.: Inhibitory effect of L-DOPA on GH release in acromegalic patients. J. Clin. Endocrinol. Metab. 35, 941–943 (1972).

    Article  CAS  PubMed  Google Scholar 

  • Liuzzi, A., Chiodini, P. G., Botalla, L., Cremascoli, G., Müller, E. E.: Decreased plasma growth hormone (GH) levels in acromegalics following CB 154 administration. J. Clin. Endocrinol. Metab. 38, 910–912 (1974).

    Article  CAS  PubMed  Google Scholar 

  • Liuzzi, A., Panerai, A. E., Chiodini, P. G., Secchi, C., Cocchi, D., Botalla, L., Silvestrini, F., Müller, E. E.: Neuroendocrine control of growth hormone secretion: Experimental and clinical studies. In: Growth Hormone and Related Peptides (Peelle, A., Müller, E. E., eds.), p. 236. Amsterdam: Excerpta Medica. 1976.

    Google Scholar 

  • MacLeod, R. M.: Regulation of prolactin secretion. In: Frontiers in Neuroendocrinology, Vol. IV (Martini, L., Ganong, W. F., eds.), p. 169. New York: Raven Press. 1976.

    Google Scholar 

  • Marko, M., Flückiger, E.: Inhibition of spontaneous and induced ovulation in rats by non-steroidal agents. Experientia 30, 1174–1176 (1974).

    Article  CAS  PubMed  Google Scholar 

  • Marko, M., Flückiger, E.: Role of serotonin in the regulation of ovulation. Evidence for pharmacological studies. Neuroendocrinology 30, 228–231 (1980).

    Article  CAS  PubMed  Google Scholar 

  • Markovitz, S., Goodyer, C. G., Guyda, H., Gardiner, R.J., Hardy, J.: Comparative study of human fetal, normal adult, and somatotropic adenoma pituitary function in tissue culture. J. Clin. Endocrinol. Metab. 54, 6–16 (1982).

    Article  Google Scholar 

  • Markstein, R.: Neuroendocrine effects of some ergot derivatives. A basis for their antiparkinson actions. J. Neural Transm. 51, 39–59 (1981).

    Article  CAS  PubMed  Google Scholar 

  • Martin, W. H., Rogol, A.D., Kaiser, D.L., Thorner, M. O.: Dopaminergic mechanism and luteinizing hormone (LH) secretion. II. Differential effects of dopamine and bromocriptine on LH release in normal women. J. Clin. Endocrinol. Metab. 52, 650–656 (1981).

    Article  CAS  PubMed  Google Scholar 

  • Mashiter, K., Adams, E., Beard, M., Holley, A.: Bromocriptine inhibits prolactin and growth hormone release by human pituitary tumours in culture. Lancet 11, 197–198 (1977).

    Article  Google Scholar 

  • Massara, F., Camanni, F., Belforte, L., Molinatti, G. M.: Dopamine-induced inhibition of prolactin and growth hormone secretion in acromegaly. Lancet 1, 485 (1976).

    Article  CAS  PubMed  Google Scholar 

  • Massara, F., Camanni, F., Belforte, L., Molinatti, G. M.: Dopamine and inhibition of prolactin and growth hormone secretion. Lancet 1, 913 (1976).

    Article  CAS  PubMed  Google Scholar 

  • Maurer, R. A.: Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells. J. Biol. Chem. 255, 8092–8097 (1980).

    CAS  PubMed  Google Scholar 

  • Maurer, R.A. (1981): Transcriptional regulation of the prolactin gene by ergocryptine and cyclic AMP. Nature 294, 94–97 (1981).

    Article  CAS  PubMed  Google Scholar 

  • Maurer, R. A.: Adenosine 3’, 5’-monophosphate derivatives increase prolactin synthesis and prolactin messenger ribonucleic acid levels in ergocryptine-treated pituitary cells. Endocrinology 110, 1957–1963 (1982).

    Article  CAS  PubMed  Google Scholar 

  • Moos, F., Richard, Ph.: Effects of dopaminergic antagonists and agonists on oxytocin release induced by various stimuli. Neuroendocrinology 28, 138–144 (1979).

    Article  CAS  PubMed  Google Scholar 

  • Munemura, M., Cote, T. E., Tsuruta, K., Eskay, R. L., Kebabian, J. W.: The dopamine receptor in the intermediate lobe of the rat pituitary gland: Pharmacological characterization. Endocrinology 107, 1676–1683 (1980 a).

    Google Scholar 

  • Munemura, M., Eskay, R.L., Kebabian, J. W.: Release of a-melanocytestimulating hormone from dispersed cells of the intermediate lobe of the rat pituitary gland. Involvement of catecholamines and adenosine 3’, 5’- monophosphate. Endocrinology 106, 1795–1803 (1980 b).

    Google Scholar 

  • Nansel, D. D., Gudelsky, G.A., Reymond, M.J., Neaves, W.B., Porter, J. C.: A possible role for lysosomes in the inhibitory action of dopamine on prolactin release. Endocrinology 108, 896–902 (1981).

    Article  CAS  PubMed  Google Scholar 

  • Penny, R.J., Thody, A.J.: Preliminary studies on the control of a-melanocytestimulating hormone secretion in the rat. J. Endocr. 69, 2–3 (1976).

    Google Scholar 

  • Penny, R.J., Tilders, F.J. H., Thody, A.J.: The role of the dopaminergic tuberohypophyseal neurones in the maintenance of “basal” melanocyte-stimulating hormone levels in the rat. J. Endocrinol. 80, 58–59 (1979).

    Google Scholar 

  • Perryman, R. L., Rogol, A. D., Kaiser, D. L., MacLeod, R. M., Thorner, M. O.: Pergolide mesylate: Its effects on circulating anterior pituitary hormones in man. J. Clin. Endocrinol. Metab. 53, 772–778 (1981).

    Article  CAS  PubMed  Google Scholar 

  • Russel, J. A., Harrison, D.J., McNeilly, A. S.: Bromocriptine and a-ergocryptine do not inhibit oxytocin secretion in the lactating rat. J. Endocr. 89, 91–98 (1981).

    Article  Google Scholar 

  • Sarkar, D.K., Fink, G.: Gonadotropin-releasing hormone surge: possible modulation through postsynaptic a-adrenoceptors and two pharmacologically distinct dopamine receptors. Endocrinology 108, 862–867 (1981).

    Article  CAS  PubMed  Google Scholar 

  • Scatton, B.: Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: Evidence against dopamine receptor multiplicity. J. Pharmacol. Exp. Therap. 220, 197–202 (1982).

    CAS  Google Scholar 

  • Scholtysik, G., Müller-Schweinitzer, E.: Evidence of presynaptic dopamine receptors in sympathetic heart nerves of cats. In: Modulation of Neurochemical Transmission (Vizi, E. S., ed.), p.189. London: Pergamon Press/ Budapest: Akadémiai Kiad 6. 1980.

    Google Scholar 

  • Seybold, V. S., Miller, J. W., Lewis, P. R.: Investigation of a dopaminergic mechanism for regulating oxytocin release. J. Pharmacol. Exp. Ther. 207, 605–610 (1978).

    CAS  PubMed  Google Scholar 

  • Thorner, M. O., Ryan, S. M., Wass, J. A. H., Jones, A., Bouloux, P., Williams, S., Besser, G. M.: Effect of the dopamine agonist lergotrile mesylate, on circulating anterior pituitary hormones in man. J. Clin. Endocrinol. Metab. 47, 372 (1978).

    Article  CAS  PubMed  Google Scholar 

  • Thorner, M. O., Flückiger, E., Calne, D. B.: Bromocriptine, A Clinical and Pharmacological Review. New York: Raven Press. 1980.

    Google Scholar 

  • Tolis, G., Pinter, E.J., Friesen, H. G.: The acute effect of 2-bromo-a-ergokryptine (CB 154) on anterior pituitary hormones and free fatty acids in man. J. Clin. Pharmacol. 12, 281–283 (1975).

    CAS  Google Scholar 

  • Tsuruta, K., Frey, E.A., Grewe, C. W, Cote, T. E., Eskay, R.L., Kebabian, J. W.: Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor. Nature 292, 463–465 (1981).

    CAS  Google Scholar 

  • Verde, G., Oppizzi, G., Colussi, G., Cremascoli, G., Botala, L., Müller, E. E., Silvestrini, F., Chiodini, P. G., Liuzzi, A.: Effect of dopamine infusion on plasma levels of growth hormone in normal subjects and in acromegalic patients. Clin. Endocrinol. 5, 419–423 (1976).

    Article  CAS  Google Scholar 

  • Vesely, D. L.: Bromocriptine enhances guanylate cyclase activity. Endocrinology 109, 1284–1286 (1981).

    Article  CAS  PubMed  Google Scholar 

  • Vigouret, J. M., Bürki, H. R., Jaton, A. L., Züger, P. E., Loew, D. M.: Neurochemical and neuropharmacological investigations with four ergot derivatives. Pharmacology 16 (Suppl. 1), 156–173 (1978).

    Article  CAS  PubMed  Google Scholar 

  • Wass, J. A. H., Clemmons, D. R., Underwood, L. E., Barrow, I., Besser, G. N., Van Wyk, J.J.: Changes in circulating somatomedin-C levels in bromocriptine-treated acromegaly. Clinical Endocrinol. (in press).

    Google Scholar 

  • Weiner, R. I., Ganong, W. F.: Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol. Revs. 58, 905–976 (1978).

    CAS  Google Scholar 

  • Woolf, P.D.: Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists. Am. J. Physiol. 240, 700–704 (1981).

    Google Scholar 

  • Yeo, T., Thorner, M. O.,Jones, A., Lowry, P.J., Besser, G. M.: The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells. Clin. Endocrinol. 10, 123–130 (1979).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Preclinical Research, Pharma Division, Sandoz Ltd., CH-4002, Basle, Switzerland

    Prof. Dr. E. Flückiger

Authors
  1. Prof. Dr. E. Flückiger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Psychiatry, New York University Medical Center, New York, N.Y., USA

    Menek Goldstein

  2. Ludwig Boltzmann-Institut für Klinische Neurobiologie und Neurologische Abteilung, Krankenhaus der Stadt Wien-Lainz, Wien, Austria

    Kurt Jellinger

  3. Ludwig Boltzmann-Institut für Klinische Neurobiologie, Krankenhaus der Stadt Wien-Lainz, Wien, Austria

    Peter Riederer

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Wien

About this paper

Cite this paper

Flückiger, E. (1983). Interactions of Ergot Compounds with Dopamine Receptors and Endocrine Functions. In: Goldstein, M., Jellinger, K., Riederer, P. (eds) Basic Aspects of Receptor Biochemistry. Journal of Neural Transmission, vol 18. Springer, Vienna. https://doi.org/10.1007/978-3-7091-4408-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-4408-4_18

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-4410-7

  • Online ISBN: 978-3-7091-4408-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation